Filter Results:
(3,152)
Show Results For
- All HBS Web
(3,152)
- People (10)
- News (972)
- Research (1,710)
- Events (6)
- Multimedia (34)
- Faculty Publications (707)
Show Results For
- All HBS Web
(3,152)
- People (10)
- News (972)
- Research (1,710)
- Events (6)
- Multimedia (34)
- Faculty Publications (707)
- 23 Jan 2008
- First Look
First Look: January 23, 2008
Molded) grommet, was supported heavily by the product development group because it was simpler to design and improved the leak seat. Process development was against using it because it cost more, complicated the manufacturing process, and... View Details
Keywords: Martha Lagace
- October 2022
- Supplement
The SAH Group: The Time is Right, Instructor Spreadsheet
By: Juan Alcacer and Alpana Thapar
In January 2021, Jalila Mezni, CEO of the SAH Group, was preparing to present the company’s future growth plans to its board of directors. The Tunisian company was a leading producer and distributor of personal care and packaged hygiene products. In 2019, it expanded... View Details
- October 2022
- Supplement
The SAH Group: The Time is Right, Spreadsheet Supplement
By: Juan Alcacer and Alpana Thapar
In January 2021, Jalila Mezni, CEO of the SAH Group, was preparing to present the company’s future growth plans to its board of directors. The Tunisian company was a leading producer and distributor of personal care and packaged hygiene products. In 2019, it expanded... View Details
- 20 Aug 2021
- Blog Post
Is the MBA Worth It? Hear What Recent HBS Grads Have to Say
full-time MBA experience once in your life. You want to make sure that you pick the right two years personally and professionally. I wouldn't worry so much about the financial component -- just focus on if the time in your life is right... View Details
- Web
Human Behavior & Decision-Making - Faculty & Research
attractive person whom they thought of spontaneously than deliberately in Study 4, and reported their commitment to a current romantic relationship would be more affected by the spontaneous than deliberate recollection of a good or bad... View Details
- 14 May 2018
- Research & Ideas
Amazon vs. Whole Foods: When Cultures Collide
co-written with James Barnett and Christine Snively. A tale of two cultures From the very start, Amazon made its name on being fast, cheap, and efficient—using data to drive its product mix and enforcing strict employee discipline to squeeze out View Details
- 14 Dec 2009
- Research & Ideas
Can Entrepreneurs Drive People Movers to Success?
personal rapid transport, or PRT for short, has been percolating since the mid-1950s and is finally gaining ground, according to HBS professor Benjamin G. Edelman. Business and communities small and large are increasingly aware of PRT as... View Details
- 21 Oct 2008
- First Look
First Look: October 21, 2008
Working PapersCan Higher Prices Stimulate Product Use? Evidence from a Field Experiment in Zambia (revised) Authors:Nava Ashraf, James Berry, and Jesse M. Shapiro Abstract The controversy over whether and how much to charge for health... View Details
Keywords: Martha Lagace
- 17 Jan 2023
- In Practice
8 Trends to Watch in 2023
As 2023 begins, businesses and employees face an uncertain economy and labor market, as the twin dilemmas of inflation and interest rates weigh on forecasts. Harvard Business School faculty share the top trends that they believe will shape the workplace and markets... View Details
Keywords: by Avery Forman
- Web
Research - Global
Sasso This follow-up case is about Meghna Modi, the CEO of struggling cosmetics company Revlon India, and the actions she takes as she tries to both turn the company around and integrate her personal purpose into her work. Influenced by... View Details
- 16 Feb 2023
- HBS Case
ESG Activists Met the Moment at ExxonMobil, But Did They Succeed?
The impact-investment hedge fund Engine No. 1 made a big splash in May 2021 when it managed to get three nominees elected to the ExxonMobil board of directors. It was an open effort to prod the oil giant toward renewable energy and test whether activist investing could... View Details
- 01 Dec 2015
- First Look
December 1, 2015
Statistics Survive Another Day: Using Changes in the Composition of Investments to Measure the Cost of Credit Constraints By: Garicano, Luis, and Claudia Steinwender Abstract—We introduce a novel empirical strategy to measure the size of... View Details
Keywords: Sean Silverthorne
- 24 Feb 2022
- Op-Ed
Want to Prevent the Next Hospital Bed Crisis? Enlist the SEC
billing rule that hospitals had ignored, it imposed a tangle of new requirements and directed the US Department of Health and Human Services (HHS) to help prevent excess out-of-network charges. And consider the HHS’s multimillion dollar... View Details
- April 2017
- Supplement
Imprimis (B)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A). It describes the company’s decision to enter into the pharmaceutical compounding business in 2013–2014. Imprimis purchased a compounded ophthalmological medication called Dropless Therapy, which was injected into patients’... View Details
Keywords: Healthcare; Drug Compounding; Drug Development; Pharmaceuticals; Small Business; Decision-making, Business Model; Mark Baum; Imprimis; Decision Making; Strategy; Health Care and Treatment; Policy; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (B)." Harvard Business School Supplement 717-496, April 2017.
- July 2019
- Article
The Impact of Price Regulation on the Availability of New Drugs in Germany
By: Ariel Dora Stern, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim and Ameet Sarpatwari
The 2011 German Pharmaceutical Market Restructuring Act (“AMNOG”) subjected branded, non-rare disease drugs to price regulation based on an assessment of their clinical benefit. Assessment outcomes range from “major added benefit” to “less benefit than the appropriate... View Details
Keywords: Regulation; Pharmaceuticals; Healthcare; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Germany
Stern, Ariel Dora, Felicitas Pietrulla, Annika Herr, Aaron S. Kesselheim, and Ameet Sarpatwari. "The Impact of Price Regulation on the Availability of New Drugs in Germany." Health Affairs 38, no. 7 (July 2019): 1182–1187.
- Web
Policies, Rules & Guidelines | About
flights; the purpose of this policy is to help clarify acceptable use and safety of UAS on or above the HBS campus. Drug & Alcohol Policy Harvard Business School’s policy on drugs and alcohol reflects our concern for the health and... View Details
- July 2021
- Article
Electronic Trace Data and Legal Outcomes: The Effect of Electronic Medical Records on Malpractice Claim Resolution Time
By: Sam Ransbotham, Eric Overby and Michael C. Jernigan
Information systems generate copious trace data about what individuals do and when they do it. Trace data may affect the resolution of lawsuits by, for example, changing the time needed for legal discovery. Trace data might speed resolution by clarifying what events... View Details
Keywords: Analytics and Data Science; Lawsuits and Litigation; Digital Transformation; Welfare; Health Industry
Ransbotham, Sam, Eric Overby, and Michael C. Jernigan. "Electronic Trace Data and Legal Outcomes: The Effect of Electronic Medical Records on Malpractice Claim Resolution Time." Management Science 67, no. 7 (July 2021): 4341–4361.
- September 1996 (Revised April 1998)
- Case
Mobil USM&R (B): New England Sales and Distribution
By: Robert S. Kaplan
The general manager of a local gasoline/distillate sales and distribution business unit must communicate a new strategy to the unit's 300 employees. An initial strategic planning exercise identified a high-priority list of opportunities that blended the parent... View Details
Keywords: Balanced Scorecard; Adoption; Strategic Planning; Customization and Personalization; Management Practices and Processes; Growth and Development Strategy; Measurement and Metrics; Motivation and Incentives; Performance Evaluation; Energy Industry; Mining Industry; United States
Kaplan, Robert S. "Mobil USM&R (B): New England Sales and Distribution." Harvard Business School Case 197-026, September 1996. (Revised April 1998.)
- November 2017
- Article
A Retrospective Analysis of Hypertension Screening at a Mass Gathering in India: Implications for Non-communicable Disease Control Strategies
By: S. Balsari, P. Vemulapalli, M. Gofine, K. Oswal, R. Merchant, S. Saunik, G. Greenough and T. Khanna
Cardiovascular disease is the leading cause of mortality from noncommunicable diseases (NCD) in India. The government’s National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke seeks to increase capacity building, screening,... View Details
Balsari, S., P. Vemulapalli, M. Gofine, K. Oswal, R. Merchant, S. Saunik, G. Greenough, and T. Khanna. "A Retrospective Analysis of Hypertension Screening at a Mass Gathering in India: Implications for Non-communicable Disease Control Strategies." Journal of Human Hypertension 31, no. 11 (November 2017): 750–753.
- Web
Business History - Faculty & Research
safety, morals, and health could be protected. Article Intermediary Functions and the Market for Innovation in Meiji and Taisho Japan By: Tom Nicholas and Hiroshi Shimizu Japan experienced a transformational phase of technological... View Details